Shockwave Therapy in Brampton

Shockwave therapy (Extracorporeal Shock Wave Therapy, ESWT) is the therapeutic application of high-energy acoustic pressure waves generated outside the body and transmitted through the skin to musculoskeletal tissue. Two distinct technologies exist. Focused ESWT (fESWT) generates high-pressure waves via electrohydraulic, electromagnetic, or piezoelectric mechanisms that converge on a precise focal depth within tissue - used primarily for deep targets (kidney stones, non-union fractures, deep calcifications). Radial ESWT (rESWT) uses a pneumatically accelerated projectile striking a metal applicator to generate a pressure wave that spreads in a divergent pattern - with maximal energy density at the skin surface, decreasing with depth, making it well-suited for superficial-to-mid-depth musculoskeletal conditions. Platinum Physiotherapy delivers radial ESWT using clinical-grade pneumatic systems.

The proposed mechanisms of action include mechanotransduction (mechanical stress converted to biological signals), controlled microtrauma triggering a healing cascade in chronically dysfunctional tissue that has stalled in a degenerative (non-inflammatory) state, stimulation of angiogenesis and neovascularization (Wang 2002 documented VEGF upregulation), disruption of calcium deposits in calcific tendinopathy, modulation of substance P and other nociceptive mediators reducing pain signaling, and stem cell recruitment at the treatment site. The overall clinical effect converts a stalled chronic degenerative tendinopathy back into an active healing state where progressive loading (the actual rehabilitation) can then drive tissue remodeling.

The evidence base is strongest for specific conditions. Plantar fasciitis: Sun 2017 meta-analysis (9 RCTs, n=935) shows ESWT significantly outperforms sham at 12-week and 6-month follow-up; Gollwitzer 2015 RCT supports focused ESWT. Achilles tendinopathy (mid-portion and insertional): Rasmussen 2008 RCT, Rompe 2009. Calcific rotator cuff tendinopathy: Bannuru 2014 systematic review supports ESWT for deposit resolution and pain. Patellar tendinopathy (jumper's knee): Vulpiani 2013. Lateral epicondylitis: mixed but moderate support. Greater trochanteric pain syndrome (trochanteric bursitis): Rompe 2009 RCT. Medial tibial stress syndrome (shin splints): Rompe 2010 RCT. Evidence is weaker for acute injuries (not indicated) and very-low-volume (only one session) protocols. We use evidence-supported protocols: typically 2000-3000 shocks per session at 1.5-3.5 bar, 8-15 Hz, 3-6 sessions at 1-week intervals.

• Chronic plantar fasciitis (>3 months duration, refractory to 4-6 weeks of appropriate stretching, orthoses, and loading) - strong evidence from Sun 2017 meta-analysis.
• Achilles tendinopathy - mid-portion (Rasmussen 2008) and insertional (Rompe 2008), typically after failed Alfredson eccentric program.
• Patellar tendinopathy (jumper's knee) - chronic cases refractory to heavy-slow-resistance (Kongsgaard 2010) or Alfredson eccentric decline-squat programs.
• Lateral epicondylitis (tennis elbow) - chronic cases after 6+ weeks of eccentric wrist extensor loading (Tyler 2014 program) with inadequate response.
• Medial epicondylitis (golfer's elbow) - chronic cases.
• Rotator cuff tendinopathy with or without calcific deposits - calcific tendinopathy particularly responsive (Bannuru 2014 systematic review).
• Greater trochanteric pain syndrome (trochanteric bursitis, gluteal tendinopathy) - chronic cases after failed loading and manual therapy (Rompe 2009).
• Proximal hamstring tendinopathy - chronic cases in runners and cyclists.
• Medial tibial stress syndrome (shin splints) - chronic cases refractory to training modification and calf loading (Rompe 2010).
• Chronic myofascial trigger points and focal muscle pain - as adjunct to dry needling and manual release.
• Scar tissue and adhesion management - post-surgical or post-traumatic fibrosis limiting function.
• Peyronie's disease, erectile dysfunction (referral to urology for fESWT under specialist supervision) - not managed in our clinic but acknowledged as emerging indication.

Shockwave is not first-line treatment. We recommend shockwave only after appropriate conservative care has been trialed - typically 4-6 weeks of correct loading (eccentric for tendinopathy, heavy-slow-resistance, progressive stretching and strengthening), manual therapy where indicated, and activity-load management. When conservative care has plateaued and the condition has become chronic (typically >3 months), shockwave is a reasonable evidence-based adjunct to re-initiate a healing response. We do not offer it as a stand-alone treatment that replaces rehabilitation - the published evidence for ESWT combined with loading programs is consistently better than ESWT alone.

Session structure (10-15 minutes per region): the target area is marked by palpation and (where appropriate) by guided by ultrasound anatomical landmarks. A thin layer of coupling gel is applied. The pneumatic applicator is placed directly on the skin over the pathology and a series of impulses is delivered. Typical dose: 2000-3000 shocks per session, frequency 8-15 Hz, energy 1.5-3.5 bar starting below the patient's tolerance threshold and progressed up within that session. You will feel a series of rapid tapping pressure impulses; most patients describe the sensation as uncomfortable but tolerable (typically rated 4-7/10 during treatment). Energy is reduced or the site shifted if the intensity exceeds tolerance.

Typical course: 3-6 sessions at 1-week intervals. We reassess at session 3 and session 6 using both pain scores and condition-specific outcome measures (VISA-A for Achilles, VISA-P for patellar, FAAM for foot/ankle, DASH/QuickDASH for upper extremity). If no meaningful response is evident by session 3-4, we re-evaluate the diagnosis and treatment plan rather than continue indefinitely.

Post-treatment: temporary post-session soreness, skin redness, or mild bruising in the treatment area over the subsequent 24-48 hours is normal and expected - the mild inflammatory response is part of the therapeutic mechanism. Unusual symptoms (severe swelling, worsening pain beyond baseline, numbness) warrant clinic follow-up. You typically continue your loading exercise program between sessions; temporary deloading for 24-48 hours post-session is often advised.

Contraindications: absolute - pregnancy (avoid abdomen/pelvis), active malignancy in treatment area, acute infection in treatment area, open growth plates directly under the treatment site (skeletally immature patients - use with caution or avoid), hemophilia or bleeding disorders, current anticoagulation with warfarin or DOAC (relative - we review with your physician), acutely fractured bone, cardiac pacemaker (relative for thoracic-region treatment), steroid injection in the same area within the last 6 weeks. Relative - severe peripheral vascular disease, deep vein thrombosis risk, children with open epiphyses (modify dose).

Integration with active rehab: every shockwave session is paired with or delivered within a physiotherapy visit that includes assessment of loading progression, tendon-specific exercise advancement (Alfredson for Achilles, Tyler for lateral epicondylitis, Kongsgaard heavy-slow-resistance for patellar, Silbernagel for Achilles insertional), manual therapy where indicated, and biomechanical review (running gait, throwing mechanics, occupational ergonomics). Shockwave without an appropriate loading program is unlikely to produce lasting benefit in tendinopathy.

Coverage: shockwave is delivered and billed under the physiotherapy benefit by Registered Physiotherapists. Some extended health plans specifically exclude shockwave as a named modality - we verify your coverage in advance and provide a pre-authorization letter if your insurer requires one. WSIB coverage depends on case approval. MVA-SABS may cover shockwave on an OCF-18 Treatment Plan if clinically indicated and approved. No doctor's referral required.